Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Metabolism & Elimination The metabolic fate and degradation pathways of MOTS-c remain incompletely characterized, representing a significant gap in pharmacokinetic understanding: Rapid plasma clearance observed in preclinical models, though precise half-life not definitively established Likely degradation through peptidase activity, though specific enzymes not identified No accumulation detected in chronic administration studies (animal models) Active metabolites not characterized
Anything below 95% should be rejected for serious research applications, as the cumulative effect of impurities over a multi-week protocol introduces unacceptable variability
Working closely with a gynecologist or reproductive endocrinologist can help address fertility concerns
The safety concern is with internet sellers that are not pharmacies, do not provide patient-specific prescriptions, or sell products with for research only disclaimers
US$ 22.42
US$ 21.79
US$ 29.05
US$ 21.44
